Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?

Authors

Keywords

CTLA-4, Ipilimumab, B7-CTLA-4 interaction, Regulatory T cells, Tumor microenvironment, Cancer immunotherapy

Journal

Volume 8, Issue 1, Pages -

Publisher

Springer Nature

Online

2018-04-18

DOI

10.1186/s13578-018-0229-z

References

View 4 related references

Contact the author

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now